Seen Health adds Aetna Medicare executive to board, names new CFO

Seen Health, a provider of PACE (Program of All-Inclusive Care for the Elderly) services, announced leadership changes aimed at strengthening its governance and finance functions. The company said it has appointed Ali Khan, MD, MPP, to its board of directors and named Mitzi Yue as chief financial officer, bringing in executives with experience across health plans and Medicare-focused care delivery.

Khan’s appointment follows his prior role as chief medical officer for Aetna’s Medicare business, according to the announcement carried by Yahoo Finance. As chief medical officer, Khan led medical strategy and oversight for Aetna’s Medicare line, a background that Seen Health may view as relevant to the clinical and regulatory demands of PACE programs, which coordinate comprehensive care for eligible older adults.

Seen Health also named Mitzi Yue as its CFO. The CFO role typically covers financial planning, capital strategy, budgeting, and reporting for a company, and it often becomes especially central for health services organizations as they scale operations, manage reimbursement risk, and invest in clinical and technology capabilities.

In describing its platform, Seen Health positions itself as culturally focused and AI-native, and it operates in the niche of PACE. PACE blends medical, social, and supportive services under a single model for seniors who qualify for nursing-home level of care, with an emphasis on keeping participants living in their communities.

Company leadership changes like these can announcement a push to deepen expertise in both payer-provider alignment and compliance-heavy operations. For PACE operators, board and C-suite appointments can also be used to reinforce relationships with regulators and payers, as PACE relies on participation in Medicare and Medicaid funding frameworks.

Still, the announcement as presented in the Yahoo Finance item does not disclose many of the details investors and operators typically look for, such as board committee assignments, the start dates for the new roles, the scope of responsibilities for the CFO position, or any associated financial targets tied to the staffing updates. It also does not provide information on whether Khan replaces a departing director or fills a new seat.

What to watch next is whether Seen Health elaborates on how these hires will affect its PACE program growth, staffing model, and technology roadmap, particularly its use of AI. Additional disclosures, such as leadership bios, governance details, or updates on expansion plans, would help clarify how the appointments translate into near-term execution.